Milton D. Goldenberg
26Patents
22h-index
4Co-inventors
78Inventor score
Filing activity: Mar 3, 1980 → Mar 4, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4331647A | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers | Human Necessities | 500 | Expired |
| US4699784A | Tumoricidal methotrexate-antibody conjugate | Emerging Cross-Sectional Technologies | 374 | Expired |
| US5057313A | Diagnostic and therapeutic antibody conjugates | Human Necessities | 274 | Expired |
| US4444744A | Tumor localization and therapy with labeled antibodies to cell surface antigens | Emerging Cross-Sectional Technologies | 215 | Expired |
| US6096289A | Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy | Human Necessities | 174 | Expired |
| US4361544A | Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers | Human Necessities | 165 | Expired |
| US4925648A | Detection and treatment of infectious and inflammatory lesions | Emerging Cross-Sectional Technologies | 154 | Expired |
| US4348376A | Tumor localization and therapy with labeled anti-CEA antibody | Human Necessities | 143 | Expired |
| US4932412A | Intraoperative and endoscopic tumor detection and therapy | Human Necessities | 127 | Expired |
| US5101827A | Lymphographic and organ imaging method and kit | Physics | 126 | Expired |
| US5697902A | Method for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 121 | Expired |
| US6387350B2 | Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy | Human Necessities | 117 | Expired |
| US6331175A | Method and kit for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 108 | Expired |
| US4624846A | Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles | Emerging Cross-Sectional Technologies | 108 | Expired |
| US4818709A | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay | Chemistry; Metallurgy | 97 | Expired |
| US4468457A | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies | Human Necessities | 62 | Expired |
| US5120525A | Radiolabeled antibody cytotoxic therapy of cancer | Human Necessities | 57 | Expired |
| US5776093A | Method for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 47 | Expired |
| US5609846A | Radiolabelled antibody cytotoxic therapy of infectious or autoimmune disease | Human Necessities | 46 | Expired |
| US5776094A | Method and kit for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 42 | Expired |
| US4460559A | Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers | Human Necessities | 38 | Expired |
| US5776095A | Method and kit for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 34 | Expired |
| US5439665A | Detection and treatment of infectious and inflammatory lesions | Human Necessities | 15 | Expired |
| US5843397A | Cytotoxic therapy for graft rejection | Human Necessities | 12 | Expired |
| US5705158A | Treatment of infectious and inflammatory lesions | Emerging Cross-Sectional Technologies | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.